To determine how these gene expression changes affected TIL protein expression, activation, and metabolism, we performed CyTOF on healthy donor PBMC or RCC TIL treated with IL-7, CD3, and CD3 with CD28. This evidence concerns the gene CD28 and renal cell carcinoma.